本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律 责任。 一、 定向回购股份注销情况 公司通过股份回购专用证券账户，共回购 24,000 股，占回购前公司总股本的比例 为 0.02%。公司已于 2026 年 3 月 20 日在中国证券登记结算有限责任公司北京分公司办 理完毕上述 24,000 股回购股份的注销手续。本次回购股份注销完成前，公司股份总额 为 124,500,000 股，本次回购股份注销完成后，公司股份总额为 124,476,000 股，公司 剩余库存股 1,684,056 股。 证券代码：920429 证券简称：康比特 公告编号：2026-019 北京康比特体育科技股份有限公司 回购股份注销完成暨股份变动公告 注：公司目前处于竞价回购实施阶段（详见公司于 2026 年 2 月 6 日披露的《回购 股份报告书》及后续进展情况相关公告），注销后的回购专户股份数量为截至 2026 年 3 月 20 日收市后情况。 北京康比特体育科技股份有限公司 董事会 2026 年 3 月 24 日 注：上述回购实施前所 ...

证券代码：920429 证券简称：康比特 公告编号：2026-018 北京康比特体育科技股份有限公司 回购进展情况公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、 回购方案基本情况 （一）审议及表决情况 北京康比特体育科技股份有限公司（以下简称"公司"）于 2026 年 1 月 9 日召开第 六届董事会第十八次会议，审议通过《关于公司回购股份方案的议案》，根据《北京证 券交易所上市公司持续监管指引第 4 号——股份回购》《公司章程》等相关规则制度规 定，本事项无需提交股东会审议。 (二)回购股份的目的 基于对公司未来发展的信心和对公司价值的认可，提升公司股票长期投资价值，综 合考虑公司经营情况、财务状况以及未来的盈利能力等因素，公司拟以自有资金及银行 提供的股票回购专项贷款资金回购公司股份。本次回购的股份将用于实施股权激励，以 此进一步完善公司治理结构，构建长期激励与约束机制，确保公司长期经营目标的实现， 提升公司整体价值。 (三)回购股份符合相关条件的情况 本次回购股份符合《北京证券交易所上市 ...

Financial Performance - The company achieved operating revenue of ¥1,158,581,305.55, representing a year-on-year increase of 11.40%[5] - Net profit attributable to shareholders decreased by 56.34% to ¥38,991,684.54 compared to the previous year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses fell by 57.85% to ¥36,742,559.54[5] - Basic earnings per share decreased by 55.56% to ¥0.32[5] - The basic earnings per share remained unchanged at ¥6.93 compared to the previous year[5] Assets and Equity - Total assets at the end of the reporting period were ¥1,237,299,337.65, an increase of 4.90% from the beginning of the period[5] - Shareholders' equity attributable to the company decreased by 0.67% to ¥853,218,965.66[5] Cost and Investment Factors - The decline in net profit was primarily due to rising prices of core raw materials, which significantly pressured the cost side[6] - The company increased its market promotion investments to expand market share, impacting profit margins[6] Financial Caution - The financial data presented is preliminary and has not been audited, cautioning investors about potential risks[7]

Consumption Trends - The emotional economy market in China is expected to exceed 20 trillion yuan in 2024, with a projected CAGR of 14% from 2025 to 2029[3][60]. - The beauty consumption market is projected to reach nearly 370 billion yuan by 2025, with the retail sales of cosmetics in China estimated at 465.3 billion yuan in 2025, reflecting a year-on-year growth of 5.1%[5][51]. - The health food market is anticipated to reach 720.3 billion yuan by 2029, driven by increasing health awareness and aging population[5]. Policy and Market Dynamics - The Chinese government has prioritized boosting consumption as a key task for 2025, with policies supporting consumption upgrades and equipment renewal[5][9]. - Changing consumer behavior emphasizes emotional value, health, and personalized consumption, indicating a shift towards emotional and social fulfillment in purchasing decisions[5][9]. Key Industry Insights - The maternal and infant food market is projected to reach approximately 55.91 billion yuan in 2024, with the number of maternal and infant chain stores increasing from 21,000 in 2019 to 32,000 in 2024[5]. - The pet economy is expected to grow significantly, with the market size reaching 701.3 billion yuan in 2024, reflecting an 18% year-on-year increase[58]. Investment Opportunities - Companies in the North Exchange related to beauty consumption include Jinbo Biological, Bawei Co., and Vicky Technology, which are positioned to benefit from the ongoing growth in the beauty sector[5][52]. - The health food sector includes leading brands like Kangbiter and Yizhi Konjac, which are well-placed to capitalize on the rising demand for health-oriented products[5].

Group 1 - The core viewpoint of the article is that Kangbiter (920429.BJ) has completed its first share buyback to instill market confidence amid weak stock performance influenced by market sentiment and sector adjustments [1][2]. Group 2 - In the past week, the main highlight for Kangbiter has been its share buyback action, where on February 10, 2026, the company announced the completion of its first buyback, acquiring 51,000 shares, which represents 0.04% of the total share capital, for a total amount of approximately 785,400 yuan, with a maximum transaction price of 15.43 yuan per share and a minimum of 15.36 yuan per share [2]. Group 3 - The recent stock performance of Kangbiter has shown a weak and volatile trend, consistent with the overall performance of the food and beverage sector. As of February 12, 2026, the closing price was 15.20 yuan, reflecting a cumulative decline of 1.68% over the past five days, with a price fluctuation range of 4.84%. On the day of the buyback announcement, February 10, the stock price fell by 0.71%, with a trading volume of approximately 13.26 million yuan and a turnover rate of 0.76%. During the same period, the food and beverage sector index decreased by 2.90%, indicating that the company's stock price volatility is primarily driven by market sentiment and sector-wide adjustments [3].

证券代码：920429 证券简称：康比特 公告编号：2026-016 北京康比特体育科技股份有限公司 首次回购股份暨回购进展情况公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、 回购方案基本情况 （一）审议及表决情况 北京康比特体育科技股份有限公司（以下简称"公司"）于 2026 年 1 月 9 日召开第 六届董事会第十八次会议，审议通过《关于公司回购股份方案的议案》，根据《北京证 券交易所上市公司持续监管指引第 4 号——股份回购》《公司章程》等相关规则制度规 定，本事项无需提交股东会审议。 (二)回购股份的目的 基于对公司未来发展的信心和对公司价值的认可，提升公司股票长期投资价值，综 合考虑公司经营情况、财务状况以及未来的盈利能力等因素，公司拟以自有资金及银行 提供的股票回购专项贷款资金回购公司股份。本次回购的股份将用于实施股权激励，以 此进一步完善公司治理结构，构建长期激励与约束机制，确保公司长期经营目标的实现， 提升公司整体价值。 (三)回购股份符合相关条件的情况 本次回购股份符合《北京 ...

1. 回购股份的基本情况 （1）回购股份种类：公司发行的人民币普通股（A 股） （2）回购用途： √实施员工持股计划或者股权激励 □减少注册资本 □转换上市公司发行的可转换为股票的公司债券 证券代码：920429 证券简称：康比特 公告编号：2026-015 北京康比特体育科技股份有限公司 回购股份报告书 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律 责任。 重要内容提示： □维护上市公司价值及股东权益所必需 （3）回购规模：不低于人民币 3,000 万元（含），不超过人民币 5，000 万元（含）。 一、 审议及表决情况 北京康比特体育科技股份有限公司（以下简称"公司"）于 2026 年 1 月 9 日召开 第六届董事会第十八次会议，审议通过《关于公司回购股份方案的议案》，根据《北 京证券交易所上市公司持续监管指引第 4 号——股份回购》《公司章程》等相关规则 制度规定，本事项无需提交股东会审议。 （4）回购价格区间：不超过 25 元/股 （5）回购资金来源：公司自有资金及中国银行股份有限公司中关村支行提供 ...

(一)信息披露义务人基本情况 | 1、基本情况 | | | | | --- | --- | --- | --- | | 信息披露义务人 | 名称 | 持股变动时间 | | | 银晖国际有限公司 | | 2026年1月7日-2026年2月2日 | | | 股票简称 | 康比特 | 证券代码 | 920429 | | 变动类型 | 增加□ 减少√ | 是否存在一致行 | 是□ 否√ | | | | 动人 | | | 是否为公司第一大股东、实际控制人或 股东、实际控制人或其一致行动人 | | 是□ 否√ | | | 2、本次权益变动情况 | | | | | 股东名称 | 变动方式 | 减持股份（股） | 减持比例 | | 银晖国际有限公司 | 集中竞价 | 290,000 | 0.2329% | （二）本次权益变动前后，信息披露义务人及其一致行动人拥有上市公司权 证券代码：920429 证券简称：康比特 公告编号：2026-014 北京康比特体育科技股份有限公司 持股5%以上股东权益变动达到1%的提示性公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真 ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for future performance [5]. Core Insights - The company is expected to achieve a net profit attributable to shareholders of approximately 0.36 billion yuan in 2025, reflecting a year-on-year decline of about 59.69% [1][5]. - The company has faced significant pressure on profit margins due to rising raw material costs, particularly for whey protein products, but has managed to improve operational efficiency and achieve a quarter-on-quarter profit turnaround in Q4 [1]. - The company has developed a patented nutritional formula "CPTpro," which enhances protein absorption rates from 91% to 98% and increases muscle synthesis rates by 1.9 times, contributing to its competitive edge in the market [2]. Financial Projections - Revenue projections for 2025 are set at 1.153 billion yuan, with expected growth rates of 10.9% in 2025, 21.4% in 2026, and 25.1% in 2027 [3]. - The net profit forecast for 2025 is 0.36 billion yuan, with subsequent projections of 0.64 billion yuan in 2026 and 1.06 billion yuan in 2027, indicating a recovery trend after the anticipated decline in 2025 [3]. - The company's price-to-earnings (P/E) ratios are projected to be 53.9 for 2025, 30.6 for 2026, and 18.3 for 2027, reflecting a decreasing trend as earnings improve [3].

Financial Forecast - The company forecasts a net profit attributable to shareholders between ¥32 million and ¥40 million for 2025, representing a decline of 64.17% to 55.21% compared to the previous year's net profit of ¥89.31 million[5]. - The net profit after deducting non-recurring gains and losses is expected to be between ¥31 million and ¥37 million, reflecting a decrease of 64.44% to 57.55% from last year's figure of ¥87.17 million[5]. - The performance forecast data is preliminary and has not yet been audited, with final figures to be disclosed in the 2025 annual report[7]. Cost Structure and Profitability - The significant decline in profit is primarily due to rising prices of core raw materials, including whey protein isolate and whey protein concentrate, which have pressured the company's cost structure and led to a substantial drop in overall gross margin[4]. Strategic Initiatives - The company plans to optimize its product structure and enhance market development and customer cultivation efforts to mitigate the impact of cost fluctuations on operational efficiency[6].